U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07430293) titled 'Hybrid Closed-Loop Insulin Delivery After Pancreatectomy' on Feb. 18.
Brief Summary: Individuals with diabetes secondary to pancreatectomy experience impaired quality of life, partly due to the challenges of managing highly variable blood glucose levels. Hybrid closed-loop (HCL) automated insulin delivery (AID) systems, widely evaluated in type 1 diabetes, may improve both metabolic outcomes and quality of life in this population.
A review of the literature identified a few observational studies reporting promising results with HCL systems in the context of post-pancreatectomy diabetes. Only one randomized trial has evaluated AID i...